1877 — Shanghai Junshi Biosciences Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$10.59bn
- HK$8.62bn
- CNY1.50bn
Annual cashflow statement for Shanghai Junshi Biosciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -444 | -795 | -1,256 | -1,452 | -1,463 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,179 | -1,456 | -605 | -1,776 | -2,005 |
| Capital Expenditures | -862 | -580 | -902 | -394 | -833 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -97.3 | -160 | -1,016 | -43.3 | -101 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -960 | -740 | -1,918 | -437 | -933 |
| Financing Cash Flow Items | 360 | 4,484 | 2,976 | 3,906 | 254 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 594 | 4,414 | 2,666 | 4,613 | 712 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,550 | 2,171 | 120 | 2,492 | -2,219 |